Explore the region. Get involved in your community. Experience moments of joy.
Delivered Tuesdays & Thursdays
CapRadio
Science, technology, environment and health news and discussion with host Ira Flatow.
Friday, noon – 1 p.m.on News Station
A 39-year-old woman, the first participant enrolled in the Phase 1 clinical trial VRC 207, received a dose of the investigational NIAID/GSK Ebola vaccine at the NIH Clinical Center in Bethesda, Maryland, on September 2, 2014.
Photo courtesy of NIAID
Ebola Vaccines Fast-Tracked As Outbreak Slows
Could This 3-D Printer Print Itself?
Scientists Sniff Smelly Comet
Countering Memory Loss With Cocoa Compounds
Creature Double Feature
Doctors ‘Unwrap’ a 3,000-Year-Old Mummy
A Haunted House Turned Scientists’ Lab
Behind the Monster Music: Why Some Tunes Scare Us